MedPring Capital AS is rated 3 out of 5 in the category medical devices. Read and write reviews about MedPring Capital AS. MedPring AS owns a worldwide patent granted in 16 countries for a medical device that enhances blood flow in penis by providing sequential axial vibrations. Patients suffering with erectile dysfunction (ED) can use the device to obtain stronger erection. The device is 100% mechanical, easy to use with no side effects, and hence a novel alternate to currently available treatment options for ED patients.
Company size
1-10 employees
Headquarters
Lysaker, Akershus